Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1335 results for "sun pharma"

Sunovion Pharmaceuticals Inc. Announces Dose Ranging Data from Phase 2 Study of SUN-101 (Glycopyrrolate) Inhal...

Sunovion Pharmaceuticals Issues Dose Ranging Data from Phase 2...

Sunovion Pharmaceuticals released dose ranging results from a Phase 2, randomized, double-blind, placebo-controlled, parallel group study of SUN-101 (glycopyrrolate inhalation solution) delivered via the proprietary eFlow nebulizer system twice a ..., 13 hours ago

24 images for sun pharma

Oneindia, 2 days ago
NDTV Profit, 2 days ago
Money Control, 2 days ago
NDTV Profit, 1 week ago
India TV, 3 weeks ago
Times of India, 3 weeks ago
Forbes India, 1 week ago
Financial Express, 3 weeks ago
NDTV, 3 weeks ago
IBN Live, 4 weeks ago
IBN Live

Mutual Funds advanced as market end strong on Fed outcome

E Among sectoral funds, Technology and FMCG Funds ended with positive returns whereas Banking & Finance Funds and Pharma & Healthcare funds ended with negative returns. Ahead of October F&O expiry tomorrow, the Nifty ended tad below 8100-mark, up ...
 Moneycontrol.com14 hours ago Sensex above 27,000; Pharma shares gain  Business Standard India1 day ago Equity NAVs end mixed as markets end flat on profit booking  Moneycontrol.com2 days ago Equity NAVs gain as markets end higher ahead state results  Moneycontrol.com1 week ago

Ranbaxy sees first profit in six qtrs on Diovan sales

Mumbai : Pharma major Ranbaxy Laboratories , on Tuesday, posted its first profit in six quarters after the company reported strong business in India and West Europe , besides receiving benefits from the launch of the generic version of Novartis AG's ...
 4 Traders6 hours ago Strong India, West Europe business helps Ranbaxy post first profit in six quarters  DNA India1 day ago Drug major Ranbaxy beats expectations, posts first profit in 6 quarters  Economic Times1 day ago Sun Pharma posts Q1 profit on strong US sales  The Financial Chronicle2 months ago

BSE Healthcare index moves up by 39% in first 10 months of 2014

Bombay Stock Exchange Healthcare (BSE HC) index of 17 major pharmaceutical and healthcare companies surged ahead by 39 per cent during the January-October 2014 and touched to 13,929.77 as at the close of October 27, 2014 with better financial ...
 PharmaBiz1 day ago Ranbaxy's return to health lifts the stock higher  Hindu Business Line2 days ago Ranbaxy Laboratories : return to health lifts the stock higher  4 Traders1 day ago
Money Control

Nifty races towards 8100 ahead of expiry; BHEL falls 1%

Tata Motors, MM, Tata Steel, Hindalco and ITC are top gainers in the Sensex. NTPC, GAIL, BHEL, Sesa Sterlite and Sun Pharma are among the laggards.
 Money Control1 day ago Sensex, Nifty flat; Sun Pharma, Sesa, Infosys slip  Money Control3 weeks ago Sensex, Nifty gain; OMCs in focus, diesel price cut likely  Money Control1 month ago Sensex, Nifty flat as traders cautious; ITC drags 1%  Money Control1 month ago

Sun Pharmaceutical's Q2 results on November 13, 2014

Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 13, 2014, inter alia, to consider and take on record the un-audited financial results of the Company for the second ...
 Moneycontrol.com1 day ago Sun Pharma to announce Q2 results on Nov 13, 2014  Equity Bulls23 hours ago Sun Pharma receives communication from CCI  Money Control2 months ago

Corporates like Sun Pharma, Palmolive spending big bucks on offsite activities to boost employee morale

Colgate Palmolive organised a mixology class followed by cocktail creating competition for its employees during its two-day offsite activity. MUMBAI: Riding high on positive economic vibes, corporates are loosening their purse strings on offsite activities to ...
 Economic Times1 day ago
Financial Express

BSE Sensex rebounds 128 pts to over 1-mth high; pharma, banking rise

The BSE benchmark Sensex today rebounded about 128 points to end at over one-month high and NSE Nifty reclaimed the 8,000-mark on the back of good corporate earnings and rising hopes of a cut in interest rates. Pharma, banking and power shares ...
 Financial Express2 days ago Sensex rebounds 128 points to over 1-month high; pharma, banking rise  ZeeNews.com2 days ago Sensex rebounds 128pts to over 1-mth high;pharma, banking rise  Business Standard India2 days ago Sensex Slips 62 Points To End Below 27k-Mark; Sun Pharma Down 4 Percent  Silicon India1 month ago

Buy Sun Pharma with a target of Rs 840: Sandeep Wagle

In a chat with ET Now, Sandeep Wagle, Founder & CEO, Power My Wealth, shares his views on Sun Pharma. ET Now: What is your call on Sun Pharma? Sandeep Wagle: Sun Pharma is a 'BUY' call with a target of Rs 840 and a stop loss of
 Economic Times2 days ago Buy Sun Pharma with a target of 840: Sandeep Wagle  Economic Times2 days ago Buy Sun Pharma; target of Rs 1033: Achiievers  Money Control3 weeks ago Buy Sun Pharma Advance with a target of Rs 200: Sandeep Wagle  Economic Times1 month ago
Business Standard

ICICI Bank, Cipla, GAIL gainers; Nifty hovers around 8000

GAIL, Sun Pharma, ICICI Bank, SBI and Cipla are top gainers in the Sensex. BHEL, HUL, Hero Moto and Reliance are among the losers.
 Money Control2 days ago Nifty breaches 8050, Sensex firm; HUL up, Wipro falls 2%  Money Control3 days ago Nifty hovers around 7,850; Infosys, Wipro top losers  Business Standard3 weeks ago CNX IT, CNX Pharma index down 2%  Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less